Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 1 country.
Matheus V C GrahlGraduate Program in Medicine and Health Sciences and Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90610-000, RS, Brazil.ORCID 0000-0002-4935-5211
Brenda da Silva AndradeLaboratory of Molecular Pharmacology, Institute of Biomedical Sciences, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21944-590, RJ, Brazil.
Ana Paula A PerinGraduate Program in Cellular and Molecular Biology, Center of Biotechnology, Federal University of Rio Grande do Sul, Porto Alegre 91501-970, RS, Brazil.
Gilda A NevesLaboratory of Molecular Pharmacology, Institute of Biomedical Sciences, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21944-590, RJ, Brazil.
Laura de Souza DuarteLaboratory of Molecular Pharmacology, Institute of Biomedical Sciences, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21944-590, RJ, Brazil.
Augusto Frantz UbertiGraduate Program in Medicine and Health Sciences and Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90610-000, RS, Brazil.ORCID 0000-0001-6382-4785
Kelvin Siqueira HohlGraduate Program in Biological Sciences-Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.ORCID 0009-0006-4474-9592
Cristian FollmerLaboratory of Biological Chemistry of Neurodegenerative Disorders, Institute of Chemistry, Department of Physical-Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, RJ, Brazil.ORCID 0000-0001-6178-0432
Celia Regina CarliniDepartment of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.ORCID 0000-0002-7027-2445
Universidade Federal do Rio de Janeiro · BRUniversidade Federal do Rio Grande do Sul · BRPontifícia Universidade Católica do Rio Grande do Sul · BR
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance code 001 and Edital Toxinologia, grant 63/2010Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul Ed. PPSUS, grant 17/2551-0001451-0National Council for Scientific and Technological Development Edital Universal, grants 820 44.6052/2014-1 and 47.5908/2012-0National Institute of Science and Technology in Brain Disease CNPq 46.5671/1-2014 and FAPERGS 823 17/2551-0000516-3
6 · The paper itself
Abstract
Intestinal dysbiosis seems to play a role in neurodegenerative pathologies. Parkinson's disease (PD) patients have an altered gut microbiota. Moreover, mice treated orally with the gut microbe
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Could the Urease of the Gut Bacterium · full record | OpenQuestion